secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001558370-22-001588
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q4 revenue $554M (+45% YoY); 2022 guidance $2.55-2.65B
--------------------------------------------------------------

- Q4 revenue $554.2M (+45% YoY); full year 2021 revenue $2.03B (+86% YoY).
- Q4 net loss improved to $0.07 per share from $3.07 loss; full year net loss $2.73 per share.
- Adjusted EBITDA Q4 $77.1M (+53% YoY); full year $267.8M (+111% YoY).
- 2022 revenue guidance $2.55-2.65B, representing 25-30% growth over 2021.
- Full year cash from operations $194.0M vs ($53.5M) prior year, a positive swing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000155837022001588/0001558370-22-001588-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000155837022001588/tdoc-20220222x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-001588

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer